glp-1 mlm Receptor Agonists: A Promising Therapy for Modern Lifestyle Diseases with Unforeseen Challenges GLP-1 use tripled among non-diabetics,

Importantly, these studies compare outcomes with those of patients receiving other diabetes medications

Figure 21: Photograph of Professor Joel Habener, credit: Endocrine Society

CONCLUSIONS Recent investigations have elucidated a multifaceted spectrum of adverse effects linked to GLP-1 RAs (Table 1), necessitating meticulous interpretation based on the various methodological designs employed, including RCTs and retrospective analyses

Additionally, the liver should theoretically compensate for hypoglycemia through gluconeogenesis

Specifically, Mller cells are important in the pathogenesis of glaucoma by providing support across the retinal span

For example, adding 2 mL to a 10 mg vial results in 5 mg/mL concentration